Who is sponsoring NCT05153707?

NCT05153707 is sponsored by Marmara University.

What drugs are being tested in NCT05153707?

Interventions in NCT05153707: Discharge Education Program.

What condition does NCT05153707 study?

NCT05153707 studies Acute Coronary Syndrome.

Is NCT05153707 still recruiting?

NCT05153707 is currently completed. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT05153707

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Pharmacist-led Discharge Education Service in Acute Coronary Syndrome

Completed NA Last updated 16 March 2023

What this trial tests

NA trial testing Discharge Education Program in Acute Coronary Syndrome in 177 participants. Completed in 15 June 2022.

Timeline

15 January 2021

Primary endpoint
15 June 2021

15 June 2022

Quick facts

Lead sponsor	Marmara University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	177
Start date	15 January 2021
Primary completion	15 June 2021
Estimated completion	15 June 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Discharge Education Program

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →

Sponsor

Marmara University

Who can join

Adults 18 to 80, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the impact of clinical pharmacist-led discharge education service in patients with acute coronary syndrome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of clinical pharmacist-led behavioural theory-based discharge service to promote medication adherence in patients with acute coronary syndrome: a randomised controlled trial.
Demirci MY, Mutlu B, Sancar M, Okuyan B. · · 2026 · PMID 41945242 · DOI 10.1007/s11096-026-02134-y

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Marmara University trials

Trials by the same sponsor.

NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05153707 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Marmara University
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05153707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing